Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Kotsopoulos J, Lubinski J, Neuhausen SL, Lynch HT, Rosen B, Ainsworth P, Moller P, Ghadirian P, Isaacs C, Karlan B, Sun P, Narod SA.
Kotsopoulos J, et al. Among authors: moller p.
Gynecol Oncol. 2006 Jan;100(1):83-8. doi: 10.1016/j.ygyno.2005.07.110. Epub 2005 Aug 31.
Gynecol Oncol. 2006.
PMID: 16137751